Compare ACHC & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACHC | OMDA |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 897.6M |
| IPO Year | N/A | 2025 |
| Metric | ACHC | OMDA |
|---|---|---|
| Price | $13.62 | $13.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 10 |
| Target Price | $20.07 | ★ $24.80 |
| AVG Volume (30 Days) | ★ 3.8M | 1.0M |
| Earning Date | 02-26-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.18 | N/A |
| Revenue | ★ $3,265,548,000.00 | $232,342,000.00 |
| Revenue This Year | $6.44 | $52.49 |
| Revenue Next Year | $3.66 | $22.68 |
| P/E Ratio | $11.20 | ★ N/A |
| Revenue Growth | 4.58 | ★ 89.23 |
| 52 Week Low | $11.43 | $14.14 |
| 52 Week High | $45.47 | $28.40 |
| Indicator | ACHC | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 29.39 |
| Support Level | $12.97 | $15.00 |
| Resistance Level | $13.67 | $17.27 |
| Average True Range (ATR) | 0.98 | 0.96 |
| MACD | 0.05 | -0.17 |
| Stochastic Oscillator | 50.46 | 2.71 |
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.